Sino Medical Sciences Stock Return On Equity
| 688108 Stock | 10.46 0.45 4.12% |
Sino Medical Sciences fundamentals help investors to digest information that contributes to Sino Medical's financial success or failures. It also enables traders to predict the movement of Sino Stock. The fundamental analysis module provides a way to measure Sino Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sino Medical stock.
Sino | Return On Equity |
Sino Medical Sciences Company Return On Equity Analysis
Sino Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sino Medical Return On Equity | -0.0047 |
Most of Sino Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sino Medical Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Sino Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Sino Medical Sciences has a Return On Equity of -0.0047. This is 99.98% lower than that of the Health Care Equipment & Supplies sector and 99.95% lower than that of the Health Care industry. The return on equity for all China stocks is 98.48% lower than that of the firm.
Sino Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sino Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sino Medical could also be used in its relative valuation, which is a method of valuing Sino Medical by comparing valuation metrics of similar companies.Sino Medical is currently under evaluation in return on equity category among its peers.
Sino Fundamentals
| Return On Equity | -0.0047 | ||||
| Return On Asset | -0.0247 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 4.42 B | ||||
| Shares Outstanding | 413.46 M | ||||
| Shares Owned By Insiders | 32.96 % | ||||
| Shares Owned By Institutions | 9.80 % | ||||
| Price To Book | 5.26 X | ||||
| Price To Sales | 11.05 X | ||||
| Revenue | 343.26 M | ||||
| Gross Profit | 121.72 M | ||||
| EBITDA | 711.57 K | ||||
| Net Income | (39.63 M) | ||||
| Total Debt | 69.27 M | ||||
| Book Value Per Share | 2.07 X | ||||
| Cash Flow From Operations | 56.84 M | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 14.0 | ||||
| Number Of Employees | 652 | ||||
| Beta | 0.53 | ||||
| Market Capitalization | 4.61 B | ||||
| Total Asset | 1.19 B | ||||
| Retained Earnings | (234.73 M) | ||||
| Working Capital | 192.9 M | ||||
| Net Asset | 1.19 B |
About Sino Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sino Medical Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sino Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sino Medical Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sino Stock
Sino Medical financial ratios help investors to determine whether Sino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sino with respect to the benefits of owning Sino Medical security.